These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 1910044)

  • 1. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.
    Seetharam S; Chaudhary VK; FitzGerald D; Pastan I
    J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor.
    Kreitman RJ; Pastan I
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):29-37. PubMed ID: 7717988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a potent chimeric toxin by replacement of domain III of Pseudomonas exotoxin with ricin A chain KDEL.
    Pitcher C; Roberts L; Fawell S; Zdanovsky AG; FitzGerald DJ; Lord JM
    Bioconjug Chem; 1995; 6(5):624-9. PubMed ID: 8974463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.
    Chaudhary VK; Jinno Y; FitzGerald D; Pastan I
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):308-12. PubMed ID: 2104981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An early step in Pseudomonas exotoxin action is removal of the terminal lysine residue, which allows binding to the KDEL receptor.
    Hessler JL; Kreitman RJ
    Biochemistry; 1997 Nov; 36(47):14577-82. PubMed ID: 9398176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds.
    Kreitman RJ; Batra JK; Seetharam S; Chaudhary VK; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1993; 4(2):112-20. PubMed ID: 7873642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha.
    Kihara A; Pastan I
    Bioconjug Chem; 1994; 5(6):532-8. PubMed ID: 7873657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant single-chain immunotoxins against T and B cell leukemias.
    Kreitman RJ; Pastan I
    Leuk Lymphoma; 1994 Mar; 13(1-2):1-10. PubMed ID: 8025511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.
    Gawlak SL; Pastan I; Siegall CB
    Bioconjug Chem; 1993; 4(6):483-9. PubMed ID: 7508267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
    Batra JK; Kasprzyk PG; Bird RE; Pastan I; King CR
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5867-71. PubMed ID: 1352878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.
    Lorberboum-Galski H; Garsia RJ; Gately M; Brown PS; Clark RE; Waldmann TA; Chaudhary VK; FitzGerald DJ; Pastan I
    J Biol Chem; 1990 Sep; 265(27):16311-7. PubMed ID: 1975810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin.
    Kreitman RJ; Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1992; 3(1):63-8. PubMed ID: 1616951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells.
    Batra JK; FitzGerald D; Gately M; Chaudhary VK; Pastan I
    J Biol Chem; 1990 Sep; 265(25):15198-202. PubMed ID: 2118522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant immunotoxin containing a disulfide-stabilized Fv directed at erbB2 that does not require proteolytic activation.
    Kuan CT; Pastan I
    Biochemistry; 1996 Mar; 35(9):2872-7. PubMed ID: 8608123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the carboxyl-terminal amino acids important for the ADP-ribosylation activity of Pseudomonas exotoxin A.
    Chow JT; Chen MS; Wu HC; Hwang J
    J Biol Chem; 1989 Nov; 264(31):18818-23. PubMed ID: 2553721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of sequences in domain II of Pseudomonas exotoxin A which mediate translocation.
    Siegall CB; Ogata M; Pastan I; FitzGerald DJ
    Biochemistry; 1991 Jul; 30(29):7154-9. PubMed ID: 1906738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the activity of barnase toxins in vitro and in vivo.
    Prior TI; Kunwar S; Pastan I
    Bioconjug Chem; 1996; 7(1):23-9. PubMed ID: 8741987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand.
    Kreitman RJ; Chaudhary VK; Siegall CB; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1992; 3(1):58-62. PubMed ID: 1616950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
    Theuer CP; FitzGerald D; Pastan I
    J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
    Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
    Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.